Upfront Combined Hydroxyurea and Imatinib versus Imatinib Monotherapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Randomized Controlled Trial

• Rituparna Chetia,
• Sarika Palepu,
• Vikramjeet Dutta,
• Arkapal Bandyopadhyay,
• Anisha Mathew,
• Sudeep Vaniyath,
• Anamika Bakliwal,
• Debranjani Chattopadhyay,
• Ashok Rajoreya,
• Puneet Dhamija,
• Manisha Naithani,
• Neha Singh,
• Uttam Kumar Nath

Affiliations

Rituparna Chetia

ORCiD

Department of Medical Oncology Haematology, All India Institute of Medical Science, Guwahati, Guwahati, Assam, India

Sarika Palepu

ORCiD

Department of Community and Family Medicine, All India Institute of Medical Science, Kalyani, Kalyani, West Bengal, India

Vikramjeet Dutta

ORCiD

Department of Microbiology, Vardhman Mahavir Medical College (VMMC) and Safdarjung Hospital, New Delhi, India

Arkapal Bandyopadhyay

ORCiD

Department of Pharmacology, All India Institute of Medical Science, Kalyani, Kalyani, West Bengal, India

Anisha Mathew

ORCiD

Department of Biochemistry, Lady Harding Medical College, New Delhi, India

Sudeep Vaniyath

Clinical Haematology and BMT, Aster Malabar Institute of Medical Sciences, Calicut, Kerala, India

Anamika Bakliwal

Department of Haemato-oncology and BMT, Venketshwar Hospital, New Delhi, India

Debranjani Chattopadhyay

Department of Clinical Haematology and BMT, Tata Medical Centre, Kolkata, West Bengal, India

Ashok Rajoreya

RJN Apollo Spectra Hospital, Gwalior, Madhya Pradesh, India

Puneet Dhamija

ORCiD

Department of Pharmacology, All India Institute of Medical Science, Rishikesh, Rishikesh, Uttarakhand, India

Manisha Naithani

ORCiD

Department of Biochemistry, All India Institute of Medical Science, Rishikesh, Rishikesh, Uttarakhand, India

Neha Singh

ORCiD

Department of Pathology, All India Institute of Medical Science, Rishikesh, Rishikesh, Uttarakhand, India

Uttam Kumar Nath

ORCiD

Department of Medical Oncology Haematology, All India Institute of Medical Science, Rishikesh, Rishikesh, Uttarakhand, India